Ewa Mrozek Selected Research

Ewa Mrozek Research Topics

Disease

16	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2005
7	Neoplasms (Cancer) 04/2015 - 06/2006
2	Neutropenia 10/2020 - 04/2011
2	Triple Negative Breast Neoplasms 10/2020 - 05/2013
2	Pathologic Complete Response 11/2017 - 04/2015
2	Disease Progression 10/2013 - 07/2012
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Fanconi Anemia (Fanconi's Anemia) 01/2020
1	Diarrhea 01/2016
1	Fatigue 01/2016
1	Stomatitis 01/2016
1	Hypersensitivity (Allergy) 07/2015
1	Carcinoma (Carcinomatosis) 04/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2014
1	Hypotension (Low Blood Pressure) 12/2014
1	Melanoma (Melanoma, Malignant) 12/2014
1	Cardiomyopathies (Cardiomyopathy) 12/2014
1	Takotsubo Cardiomyopathy 12/2014
1	Circulating Neoplastic Cells 03/2014
1	Vomiting 10/2013
1	Nausea 10/2013
1	Opportunistic Infections (Opportunistic Infection) 05/2013
1	Lymphopenia (Lymphocytopenia) 05/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2011
1	Agranulocytosis (Granulocytopenia) 04/2011
1	Thyroid Neoplasms (Thyroid Cancer) 06/2006
1	Thyroid Nodule (Nodule, Thyroid) 06/2006

Drug/Important Bio-Agent (IBA)

6	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 07/2012
4	Docetaxel (Taxotere)FDA Link 12/2014 - 06/2006
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2017 - 04/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017 - 04/2008
2	Carboplatin (JM8)FDA LinkGeneric 10/2020 - 01/2020
2	Hormones (Hormone)IBA 01/2020 - 01/2016
2	Trastuzumab (Herceptin)FDA Link 04/2015 - 12/2014
2	taxaneIBA 12/2014 - 07/2012
2	Celecoxib (Celebrex)FDA Link 08/2011 - 06/2006
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 10/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2020
1	veliparibIBA 01/2020
1	Everolimus FDA Link 01/2016
1	Lapatinib (GW572016)FDA Link 04/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2014
1	Bevacizumab (Avastin)FDA Link 12/2014
1	Interleukin-2 (IL2)IBA 12/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014
1	Epithelial Cell Adhesion MoleculeIBA 03/2014
1	Palonosetron (Aloxi)FDA Link 10/2013
1	Ondansetron (Zofran)FDA LinkGeneric 10/2013
1	AntiemeticsIBA 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 05/2013
1	Bendamustine Hydrochloride FDA Link 05/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2013
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	Suramin (Suramin Sodium)IBA 07/2012
1	Taxoids (Taxanes)IBA 07/2012
1	Progesterone FDA LinkGeneric 08/2011
1	exemestane (Aromasin)FDA Link 08/2011
1	Estrogen ReceptorsIBA 08/2011
1	Nucleic AcidsIBA 04/2011
1	NSC 366140 (pyrazoloacridine)IBA 04/2011
1	Capecitabine (Xeloda)FDA Link 06/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2006
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2006

Therapy/Procedure

10	Therapeutics 01/2020 - 03/2005
3	Neoadjuvant Therapy 10/2020 - 10/2012
3	Drug Tapering 10/2020 - 04/2011
3	Drug Therapy (Chemotherapy) 11/2017 - 10/2013
1	Adjuvant Chemotherapy 11/2017
1	Premedication 07/2015